HMT Limited delays FY26 audited results submission

1 min read     Updated on 21 May 2026, 07:16 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

HMT Limited has announced a delay in submitting the audited financial results for the quarter and financial year ended March 31, 2026, missing the May 30, 2026 deadline. The delay is attributed to the ongoing consolidation of accounts and audit processes across its various units in India. The company is making efforts to finalize and submit the standalone and consolidated results at the earliest.

powered bylight_fuzz_icon
40799884

*this image is generated using AI for illustrative purposes only.

HMT Limited has informed the exchanges that it is unable to submit the audited financial results for the quarter and financial year ended March 31, 2026, by the stipulated deadline of May 30, 2026. The disclosure was made in compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015.

The company stated that the delay is due to the ongoing consolidation of accounts and audit activities across its various units located throughout India. As these processes are currently in progress, the finalization of the figures could not be completed in time for the scheduled submission date.

Reason for Delay

The primary reason cited for the inability to meet the regulatory timeline is the geographical spread of the company's operations. With units across the country, the consolidation and audit procedures require more time than initially anticipated to ensure accuracy.

Next Steps

Despite the current setback, HMT Limited has assured the exchanges that it is making concerted efforts to finalize the accounts. The company intends to submit the standalone and consolidated financial results at the earliest possible opportunity.

Detail Information
Financial Year End March 31, 2026
Regulatory Deadline May 30, 2026
Status Delayed

Historical Stock Returns for HMT

1 Day5 Days1 Month6 Months1 Year5 Years
+1.01%+0.35%-8.75%+14.79%+8.57%+104.90%

What potential penalties or regulatory actions could SEBI impose on HMT Limited for missing the May 30, 2026 deadline under LODR Regulations?

How might the delayed financial results impact HMT Limited's stock price and investor confidence in the near term?

Could the consolidation challenges across HMT's units indicate deeper operational or financial restructuring issues that investors should monitor?

HMT Limited Announces Cessation of Dr. Kartik Chandulal Bhadra as Independent Director

1 min read     Updated on 28 Mar 2026, 07:06 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

HMT Limited disclosed the cessation of Dr. Kartik Chandulal Bhadra as Non-Official Independent Director effective March 28, 2026, due to completion of his directorial term. The announcement was made in compliance with SEBI (LODR) Regulations 2015, with proper disclosure to BSE and NSE. This represents a routine term completion rather than resignation or removal.

powered bylight_fuzz_icon
36207398

*this image is generated using AI for illustrative purposes only.

HMT Limited has announced the cessation of Dr. Kartik Chandulal Bhadra as Non-Official Independent Director effective March 28, 2026. The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, informing both BSE Limited and National Stock Exchange of India Limited about this board change.

Cessation Details

The cessation is due to the completion of Dr. Bhadra's term as Non-Official Independent Director, marking a routine conclusion of his directorial tenure rather than resignation or removal. The company has provided comprehensive details as required under SEBI listing regulations.

Parameter Details
Reason for Change Cessation due to completion of term as Non-Official Independent Director
Effective Date March 28, 2026
Nature of Cessation Completion of directorial term
Regulatory Compliance SEBI (LODR) Regulations 2015, Regulation 30

Regulatory Compliance

HMT Limited has fulfilled all disclosure requirements under SEBI regulations, providing detailed information through Annexure-A as mandated by SEBI Master Circular. The company confirmed that standard disclosures regarding resignation letters, detailed reasons, and other material information are not applicable since this is a term completion rather than voluntary resignation.

Company Communication

The disclosure was signed by Kishor Kumar S, Assistant General Manager (Company Secretary), on March 27, 2026. The communication was addressed to both major stock exchanges where HMT Limited shares are listed - BSE Limited (Scrip Code: 500191) and National Stock Exchange of India Limited (Scrip Code: HMT).

Administrative Process

As this cessation results from natural term completion, several standard requirements typically associated with director resignations do not apply. These include submission of resignation letters with detailed reasons, confirmation of no other material reasons for departure, and disclosure of other listed entity directorships held by the departing director.

The company has maintained transparency in its board governance by promptly disclosing this change to stakeholders and regulatory authorities, ensuring compliance with all applicable listing obligations and disclosure requirements.

Historical Stock Returns for HMT

1 Day5 Days1 Month6 Months1 Year5 Years
+1.01%+0.35%-8.75%+14.79%+8.57%+104.90%

Who will HMT Limited appoint as Dr. Bhadra's replacement and what expertise will the new independent director bring to the board?

How might this board composition change affect HMT Limited's strategic decision-making and governance practices going forward?

Will HMT Limited need to reconstitute any board committees where Dr. Bhadra served as a member following his departure?

More News on HMT

1 Year Returns:+8.57%